Malignant Liver Non-Epithelial Neoplasm — Rankings

Malignant Liver Non-Epithelial Neoplasm — Rankings · CancerIndex

Rankings

Why this rank?

3 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.

Metric	Scope	Rank / eligible	Δ	Value	Percentile	Confidence	Formula	Generated	Inputs
Active clinical trials	World · both sexes · all ages · latest · all malignant entities	#644 / 1,654	=	8 count	61.1	Medium confidence	ci-active-trials-v1	Sep 30, 2026	show formula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING) counter activeTrialCount computedAt 2026-09-30T06:00:02.308Z inputs hash d8f333d5bfdbadb41c05f9e2 Trace lineage (admin)
Recruiting clinical trials	World · both sexes · all ages · latest · all malignant entities	#744 / 1,284	=	2 count	42.1	Medium confidence	ci-recruiting-trials-v1	Sep 30, 2026	show formula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL counter recruitingTrialCount computedAt 2026-09-30T06:00:02.308Z inputs hash 00002505dcded3e0217a182d Trace lineage (admin)
Trial termination share	World · both sexes · all ages · latest · all malignant entities	#365 / 454	=	0.29 ratio	19.6	Medium confidence	ci-trial-termination-v1	Sep 30, 2026	show formula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL asOf 2026-09-30 since 2010-01-01 terminal 38 completed 27 studyType INTERVENTIONAL withdrawn 4 terminated 7 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING

Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.

"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.

Why this rank?

Research gap